.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Queensland Health
Chubb
Express Scripts
US Army
Covington
AstraZeneca
Healthtrust
Medtronic

Generated: December 15, 2017

DrugPatentWatch Database Preview

SANDOSTATIN Drug Profile

« Back to Dashboard

Which patents cover Sandostatin, and when can generic versions of Sandostatin launch?

Sandostatin is a drug marketed by Novartis and is included in two NDAs. There are two patents protecting this drug.

The generic ingredient in SANDOSTATIN is octreotide acetate. There are eighteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the octreotide acetate profile page.
Drug patent expirations by year for SANDOSTATIN

Pharmacology for SANDOSTATIN

Medical Subject Heading (MeSH) Categories for SANDOSTATIN

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
NovartisSANDOSTATINoctreotide acetateINJECTABLE;INJECTION019667-001Oct 21, 1988APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
NovartisSANDOSTATIN LARoctreotide acetateINJECTABLE;INJECTION021008-001Nov 25, 1998RXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
NovartisSANDOSTATINoctreotide acetateINJECTABLE;INJECTION019667-003Oct 21, 1988APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
NovartisSANDOSTATIN LARoctreotide acetateINJECTABLE;INJECTION021008-002Nov 25, 1998RXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
NovartisSANDOSTATINoctreotide acetateINJECTABLE;INJECTION019667-002Oct 21, 1988APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
NovartisSANDOSTATINoctreotide acetateINJECTABLE;INJECTION019667-004Jun 12, 1991APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
NovartisSANDOSTATIN LARoctreotide acetateINJECTABLE;INJECTION021008-001Nov 25, 1998RXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
NovartisSANDOSTATINoctreotide acetateINJECTABLE;INJECTION019667-005Jun 12, 1991APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
NovartisSANDOSTATIN LARoctreotide acetateINJECTABLE;INJECTION021008-003Nov 25, 1998RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
NovartisSANDOSTATIN LARoctreotide acetateINJECTABLE;INJECTION021008-003Nov 25, 1998RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: SANDOSTATIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
NovartisSANDOSTATINoctreotide acetateINJECTABLE;INJECTION019667-004Jun 12, 1991► Subscribe► Subscribe
NovartisSANDOSTATINoctreotide acetateINJECTABLE;INJECTION019667-001Oct 21, 1988► Subscribe► Subscribe
NovartisSANDOSTATINoctreotide acetateINJECTABLE;INJECTION019667-003Oct 21, 1988► Subscribe► Subscribe
NovartisSANDOSTATINoctreotide acetateINJECTABLE;INJECTION019667-003Oct 21, 1988► Subscribe► Subscribe
NovartisSANDOSTATINoctreotide acetateINJECTABLE;INJECTION019667-004Jun 12, 1991► Subscribe► Subscribe
NovartisSANDOSTATINoctreotide acetateINJECTABLE;INJECTION019667-002Oct 21, 1988► Subscribe► Subscribe
NovartisSANDOSTATINoctreotide acetateINJECTABLE;INJECTION019667-005Jun 12, 1991► Subscribe► Subscribe
NovartisSANDOSTATINoctreotide acetateINJECTABLE;INJECTION019667-002Oct 21, 1988► Subscribe► Subscribe
NovartisSANDOSTATINoctreotide acetateINJECTABLE;INJECTION019667-005Jun 12, 1991► Subscribe► Subscribe
NovartisSANDOSTATINoctreotide acetateINJECTABLE;INJECTION019667-002Oct 21, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Novartis
Merck
Queensland Health
Colorcon
QuintilesIMS
Harvard Business School
Express Scripts
Chubb
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot